$Sanara MedTech (SMTI.US)$ Biomimetic Innovations Ltd, an affiliate of PBC Biomed, Announces an Exclusive License and Distribution Agreement and Minority Investment with Sanara MedTech Inc. Friday, 24th January at 7:00 am SHANNON, Ireland, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Irish medical device company Biomimetic Innovations Limited, an affiliate of PBC Biomed, today announced the execution of an exclusive license and distribution agreement with Sanara MedTech Inc ("Sanara") (NASDAQ: SMTI). I...
$Sanara MedTech (SMTI.US)$ Sanara MedTech Inc. Announces Exclusive License and Distribution Agreement with, and Minority Investment in, Biomimetic Innovations Ltd Tuesday, 21st January at 4:10 pm OsStic® and related technologies represent differentiated solutions that address an estimated 100,000+ procedures in the U.S. annually(1); arrangement leverages Sanara's existing call points and commercial infrastructure, and complements Sanara's existing surgical portfolio FORT WORTH, TX, Jan. 21,...
$Sanara MedTech (SMTI.US)$ Sanara MedTech Inc. Reports Unaudited Preliminary Results for the Fourth Quarter and Full Year 2024 Tuesday, 21st January at 4:05 pm Fourth Quarter Net Revenue Expected to Increase 45% to 48% Year-Over-Year; Full Year Net Revenue Expected to Increase 32% to 33% Year-Over-Year FORT WORTH, TX, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. ("Sanara," the "Company," "we," "our" or "us") (NASDAQ: SMTI), a medic...
Sanara MedTech's balance sheet is strained due to liabilities and lack of profitability. Its use of debt is risky, given its negative EBIT and free cash flow. However, its top-line growth is viewed positively.
Analysts anticipate breakeven for Sanara MedTech within a year, indicating bullish outlook. The prospects hinge on company's maintenance of robust 225% annual growth rate. The firm's low debt, majorly equity-funded, reduces investment risk.
Sanara MedTech Stock Forum
Biomimetic Innovations Ltd, an affiliate of PBC Biomed, Announces an Exclusive License and Distribution Agreement and Minority Investment with Sanara MedTech Inc.
Friday, 24th January at 7:00 am
SHANNON, Ireland, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Irish medical device company Biomimetic Innovations Limited, an affiliate of PBC Biomed, today announced the execution of an exclusive license and distribution agreement with Sanara MedTech Inc ("Sanara") (NASDAQ: SMTI). I...
Sanara MedTech Inc. Announces Exclusive License and Distribution Agreement with, and Minority Investment in, Biomimetic Innovations Ltd
Tuesday, 21st January at 4:10 pm
OsStic® and related technologies represent differentiated solutions that address an estimated 100,000+ procedures in the U.S. annually(1); arrangement leverages Sanara's existing call points and commercial infrastructure, and complements Sanara's existing surgical portfolio
FORT WORTH, TX, Jan. 21,...
Sanara MedTech Inc. Reports Unaudited Preliminary Results for the Fourth Quarter and Full Year 2024
Tuesday, 21st January at 4:05 pm
Fourth Quarter Net Revenue Expected to Increase 45% to 48% Year-Over-Year; Full Year Net Revenue Expected to Increase 32% to 33% Year-Over-Year
FORT WORTH, TX, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. ("Sanara," the "Company," "we," "our" or "us") (NASDAQ: SMTI), a medic...
NEWS
Sanara MedTech Inc. Announces $55 Million Debt Facility
No comment yet